Phase III Randomized Control Trial Investigating Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Patients With Gynecologic Malignancies Receiving Every 3-week Carboplatin and Paclitaxel Chemotherapy
Latest Information Update: 13 Jun 2024
At a glance
- Drugs Olanzapine (Primary) ; Dexamethasone; Fosaprepitant; Ondansetron; Ondansetron; Prochlorperazine
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 06 Jun 2024 Status changed from active, no longer recruiting to discontinued. (Reason the study was stopped: Lack of Patient Population)
- 26 Feb 2024 Status changed from recruiting to active, no longer recruiting.
- 11 Sep 2023 Planned End Date changed from 1 Aug 2023 to 1 Mar 2024.